First Mercantile Trust’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-4,771
Closed -$345K 933
2018
Q1
$345K Buy
4,771
+538
+13% +$38.9K 0.07% 331
2017
Q4
$279K Buy
4,233
+1,519
+56% +$100K 0.05% 431
2017
Q3
$136K Buy
+2,714
New +$136K 0.02% 648
2016
Q2
Sell
-10,054
Closed -$170K 888
2016
Q1
$170K Sell
10,054
-1,468
-13% -$24.8K 0.02% 614
2015
Q4
$256K Buy
11,522
+2,167
+23% +$48.1K 0.03% 606
2015
Q3
$221K Buy
9,355
+1,900
+25% +$44.9K 0.02% 638
2015
Q2
$610K Buy
7,455
+2,200
+42% +$180K 0.05% 440
2015
Q1
$487K Buy
+5,255
New +$487K 0.04% 505